UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549 

 


 

FORM 10-Q

 


 

 

(Mark One)

☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended:   September 30, 2021

 

☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ____________________ to ____________________.

 

Commission file number: 000-50053

AMERITYRE20210930_10QIMG001.JPG

AMERITYRE CORPORATION

(Exact name of small business issuer as specified in its charter)

 

NEVADA

87-0535207

(State or other jurisdiction of

(I.R.S. Employer

incorporation or organization)

Identification No.)

 

1501 Industrial Rd., Boulder City, NV

89005

(Address of principal executive offices)

(Zip Code)

 

(702) 293-1930

(Issuer’s telephone number)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒   No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes ☒    No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer  ☐

Accelerated filer  ☐ 

Non-accelerated filer  ☒

Smaller reporting company ☒

       

Emerging Growth Companies ☐

     

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ☐  No ☒

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

N/A

N/A

N/A

 

The number of shares outstanding of Registrant’s Common Stock as of November 15, 2021: 73,047,868

 

 

 

 

TABLE OF CONTENTS

 

   

Page

PART I

Item 1.

Financial Statements

3

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operation

10

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

16

Item 4.

Controls and Procedures

16

PART II

Item 1.

Legal Proceedings

17

Item 1A.

Risk Factors

17

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

17

Item 3.

Defaults Upon Senior Securities

17

Item 4.

Not Applicable

17

Item 5.

Other Information

17

Item 6.

Exhibits

17

     

SIGNATURES

18

 

 

 

 

PART I - FINANCIAL INFORMATION

 

ITEM 1.  FINANCIAL STATEMENTS

 

AMERITYRE CORPORATION

Balance Sheets 

 

   

September 30, 2021

   

June 30, 2021

 

ASSETS

 

(Unaudited)

         
                 

CURRENT ASSETS

               

Cash

  $ 476,220     $ 516,192  

Accounts receivable

    530,940       728,315  

Current inventory - net

    739,188       659,333  

Prepaid and other current assets

    144,412       94,483  

Total Current Assets

    1,890,760       1,998,323  
                 

RIGHT TO USE LEASE ASSETS, OPERATING, NET

    506,473       544,070  
                 

PROPERTY AND EQUIPMENT

               

Molds and models

    583,611       583,611  

Equipment

    3,077,255       2,910,018  

Furniture and fixtures

    73,423       73,423  

Software

    233,528       233,528  

Construction in progress

    14,006       -  

Less – accumulated depreciation

    (3,705,284

)

    (3,690,515

)

Property and Equipment - net

    276,539       110,065  
                 

OTHER ASSETS

               

Patents and trademarks – net

    71,043       75,977  

Non-current inventory

    164,171       163,289  

Deposits

    11,000       11,000  

Total Other Assets

    246,214       250,266  

TOTAL ASSETS

  $ 2,919,986     $ 2,902,724  
                 

LIABILITIES AND STOCKHOLDERS’ EQUITY

               
                 

CURRENT LIABILITIES

               

Accounts payable and accrued expenses

  $ 706,866     $ 767,193  

Current portion of long-term debt

    2,000       2,000  

Current portion of lease liability

    148,050       147,600  

Deferred revenue

    42,125       25,892  

Total Current Liabilities

    899,041       942,685  
                 

Long-term debt

    61,326       61,326  

Long-term lease liability

    263,250       300,600  

TOTAL LIABILITIES

    1,223,617       1,304,611  
                 

COMMITMENTS AND CONTINGENCIES  

               
                 

STOCKHOLDERS’ EQUITY

               

Common stock: 100,000,000 shares authorized of $0.001 par value, 73,047,868 and 73,047,868 shares issued and outstanding, respectively

    73,048       73,048  

Additional paid-in capital

    62,805,404       62,805,404  

Stock payable

    33,156       -  

Accumulated deficit

    (61,215,239

)

    (61,280,339

)

Total Stockholders’ Equity

    1,696,369       1,598,113  

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY 

  $ 2,919,986     $ 2,902,724  

 

The accompanying notes are an integral part of these financial statements.

 

 

AMERITYRE CORPORATION

Statements of Operations

(Unaudited)

 

   

For the Three Months Ended

September 30,

 
   

2021

   

2020

 
                 

NET SALES

 

$

1,395,614

   

$

1,051,286

 
                 

COST OF REVENUES

   

1,010,842

     

707,566

 
                 

GROSS PROFIT

   

384,772

     

343,720

 
                 

EXPENSES

               

Research and development

   

21,567

     

20,471

 

Sales and marketing

   

68,373

     

59,800

 

General and administrative

   

232,848

     

210,486

 
                 

Total Expenses

   

322,788

     

290,757

 
                 

INCOME FROM OPERATIONS

   

61,984

     

52,963

 
                 

OTHER INCOME (EXPENSE)

               

Interest income

   

366

     

418

 

Loss on asset disposal

   

-

     

(2,853

)

Other income

   

2,750

     

3,255

 
                 

Total Other Income, net

   

3,116

     

820

 
                 

NET INCOME

 

$

65,100

   

$

53,783

 
                 

BASIC AND DILUTED INCOME PER SHARE

 

$

0.00

   

$

0.00

 
                 

WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING

   

73,047,868

     

70,172,868

 

 

The accompanying notes are an integral part of these financial statements.

 

 

AMERITYRE CORPORATION

Statements of Stockholders Equity

(Unaudited)

 

   

Common Stock

   

Additional

Paid in

   

Stock

   

Accumulated

         
   

Shares

   

Amount

   

Capital

   

Payable

   

Deficit

   

Total

 

Balance, June 30, 2020

    70,172,868     $ 70,173     $ 62,719,473     $ -     $ (61,538,675

)

  $ 1,250,971  

Stock option based compensation expense – options

    -       -       -       12,323       -       12,323  

Net income for the quarter

    -       -       -       -       53,783       53,783  

Balance, September 30, 2020

    70,172,868       70,173       62,719,473       12,323       (61,484,892

)

    1,317,077  

Stock option based compensation expense – options

    -       -       -       (12,323

)

    -       (12,323 )

Stock based compensation expense for employee and Board of Director service

    1,250,000       1,250       22,560       -       -       23,810  

Net loss for the quarter

    -       -       -       -       176,852       176,852  

Balance, December 31, 2020

    71,422,868       71,423       62,742,033       -       (61,308,040

)

    1,505,416  

Stock option based compensation expense – options

    -       -       -       31,590       -       31,590  

Net income for the quarter

    -       -       -       -       80,651       80,651  

Balance, March 31, 2021

    71,422,868       71,423       62,742,033       31,590       (61,227,389

)

    1,617,657  

Stock option based compensation expense – options

    -       -       -       33,406       -       33,406  

Stock based compensation expense for employee and Board of Director service

    1,625,000       1,625       63,371       (64,996

)

    -       -  

Net loss for the quarter

    -       -       -       -       (52,950

)

    (52,950 )

Balance, June 30, 2021

    73,047,868       73,048       62,805,404       -       (61,280,339

)

    1,598,113  

Stock based compensation expense for employee and Board of Director service

    -       -       -       33,156       -       33,156  

Net income for the quarter

    -       -       -       -       65,100       65,100  

Balance, September 30, 2021

    73,047,868     $ 73,048     $ 62,805,404     $ 33,156     $ (61,215,239

)

  $ 1,696,369  

 

The accompanying notes are an integral part of these financial statements.

 

 

AMERITYRE CORPORATION

Statements of Cash Flows

(Unaudited)

 

   

For the Three Months Ended

September 30,

 
   

2021

   

2020

 

CASH FLOWS FROM OPERATING ACTIVITIES

               

Net income

  $ 65,100     $ 53,783  

Adjustments to reconcile net income to net cash provided (used) by operating activities:

               

Depreciation and amortization expense

    60,050       55,062  

Stock based compensation

    33,156       12,323  

Loss on asset disposal

    -       2,853  

Changes in operating assets and liabilities:

               

Accounts receivable

    197,375       (30,611

)

Prepaid and other current assets

    (86,256

)

    (39,668

)

Inventory and any change in inventory reserve

    (80,737

)

    (13,144

)

Accounts payable and accrued expenses

    (74,332

)

    (57,116

)

Deferred revenue

    16,233       5,475  

Lease liability payable, operating lease

    (36,901

)

    (36,450

)

Net Cash Provided (Used) by Operating Activities

    93,688       (47,493

)

                 

CASH FLOWS FROM INVESTING ACTIVITIES

               

Purchase of property and equipment

    (130,910

)

    -  

Cash paid for leasehold improvements of an operating lease

    (2,750

)

    -  

Net Cash Used by Investing Activities

    (133,660

)

    -  
                 

CASH FLOWS FROM FINANCING ACTIVITIES

               

Payments on notes payable

    -       (263

)

Net Cash Used by Financing Activities

    -       (263

)

                 

NET DECREASE IN CASH

    (39,972

)

    (47,756

)

CASH AT BEGINNING OF PERIOD

    516,192       666,756  

CASH AT END OF PERIOD

  $ 476,220     $ 619,000  

 

NON-CASH FINANCING ACTIVITIES

               
                 

Interest paid

  $ -     $ -  

Income taxes paid

    -       -  
                 

SUPPLEMENTAL SCHEDULE OF CASH FLOW ACTIVITIES

               
                 

Use of store inventory, capitalized as fixed asset

  $ -     $ 6,600  

Prepaid asset applied to capitalized equipment

  $ 36,327     $ -  

Costs accrued for construction in progress

  $ 14,006     $ -  

 

The accompanying notes are an integral part of these financial statements.

 

 

AMERITYRE CORPORATION

Notes to the Unaudited Condensed Financial Statements

September 30, 2021

 

NOTE 1 – BASIS OF FINANCIAL STATEMENT PRESENTATION

 

The accompanying unaudited condensed financial statements have been prepared by us pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”).  Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted in accordance with such rules and regulations.  The information furnished in the interim condensed financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements.  We believe the disclosures and information presented are adequate to make the information not misleading.  These interim condensed financial statements should be read in conjunction with our most recent audited financial statements and notes thereto included in our June 30, 2021 Annual Report on Form 10-K.  Operating results for the quarter ended September 30, 2021 are not necessarily indicative of the results that may be expected for the current fiscal year ending June 30, 2022.

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Significant accounting policies disclosed herein have not changed since our audited financial statements and notes thereto included in our June 30, 2021 Annual Report on Form 10-K, except as noted below.

 

Revenue Recognition

 

The majority of our revenue is derived from short-term sales contracts. We account for revenue in accordance with Accounting Standards Codification (“ASC”) Topic 606, “Revenue from Contracts with Customers”.

 

Revenue for our products is recognized at the time in which our performance obligation is satisfied which we have defined as “control” of the product by the customer. “Control” is defined as a customer having “rights/obligations of physical control over the product or has the rights and intention to control the product.” Based on the terms of our contracts, a customer’s “control” is based on analysis of the following; (i) when a customer arranges their own shipping, and once the product has left our dock, Amerityre Corporation (“Amerityre” or the “Company”) recognizes revenue for the product.  In effect by arranging their own shipping the customer is “taking control” of the product when it leaves our warehouse; or (ii) when a customer does not arrange their own shipping, we cannot recognize revenue until it is delivered and the customer takes “control” of the product. This establishes a “deferred revenue” event until such time as delivery of the product has been completed and we have proof from the shipper of the delivery (and change in control).

 

Deferred revenue was $42,125, inclusive of $45 of shipping and handling revenue (see below), as of September 30, 2021.  Deferred revenue was $17,667, inclusive of $1,633 of shipping and handling revenue (see below), as of September 30, 2020. 

 

Shipping and Handling

 

Shipping and Handling Fees require that freight costs charged to customers be classified as revenues. Freight expenses are included in costs of sales and are recognized as incurred.  Due to our adoption of ASC 606 as discussed above, we defer the revenues of shipping and handling until the related revenue is also recognized.

 

The result of this accounting is a deferral of $45 as of September 30, 2021 and $1,633 as of September 30, 2020.

 

Basic and Fully Diluted Net Income (Loss) Per Share

 

Basic and Fully Diluted net income (loss) per share is computed using the weighted-average number of common shares outstanding during the period.

 

Our outstanding stock options have been excluded from the basic and fully diluted net income per share calculation.  We excluded 1,030,000 and 2,870,000 common stock equivalents for the quarters ended September 30, 2021 and 2020, respectively, because they are anti-dilutive.

 

 

AMERITYRE CORPORATION

Notes to the Unaudited Condensed Financial Statements

September 30, 2021

 

Recent Accounting Pronouncements

 

Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the SEC, did not, or are not believed by management to, have a material impact on the Company's present or future financial position, results of operations or cash flows.

 

NOTE 3 – INVENTORY

 

Inventory is stated at the lower of cost (computed on a first-in, first-out basis) or net realizable value.  The inventory consists primarily of chemicals, finished goods produced in our plant and products purchased for resale.

 

   

September 30, 2021

   

June 30, 2021

 
   

(Unaudited)

         

Raw Materials

  $ 444,027     $ 416,709  

Finished Goods

    579,110       525,565  

Inventory reserve

    (119,778

)

    (119,652

)

Inventory – net (current and long term)

  $ 903,359     $ 822,622  

 

Our inventory reserve reflects items that were deemed to be defective or obsolete based on an analysis of all inventories on hand.

 

The Company critically reviews all slow moving inventory to determine if it is defective or obsolete.  If not defective or obsolete we present these items as non-current inventory, although all inventory is ready and available for sale at any moment.  

 

NOTE 4 RIGHT TO USE LEASE ASSETS

 

Based on our lease accounting policy, we have identified the following operating leases. As of September 30, 2021, we have no financing leases:

 

   

September 30, 2021

   

June 30,  2021

 
   

(Unaudited)

         

Facility lease

  $ 411,300     $ 448,200  

Leasehold improvements related to our facility

    289,604       286,854  

Accumulated amortization – leasehold improvements

    (194,431

)

    (190,984

)

Right to use leased assets, operating, net

  $ 506,473     $ 544,070  

 

In March 2019 we negotiated a five year extension of the lease on our executive office and manufacturing facility located at 1501 Industrial Road, Boulder City, Nevada.  The property consists of a 49,200 square foot building.  We currently occupy all 49,200 square feet, inclusive of approximately 5,500 square feet of office space, situated on approximately 4.15 acres.  Our remaining liability under this agreement is $411,300, payable at amounts ranging from $11,750 to $12,600 a month until June 30, 2024.

 

NOTE 5 – DEBT

 

A former board member, Silas O. Kines, who passed away on January 11, 2012, was also the principal owner of Forklift Tire of Florida and K-2 Industrial Tire, Inc.  In accordance with the Commission Agreement with Forklift Tire of Florida, dated February 2, 2011, between Amerityre Corporation and K-2 Industrial Tire, Inc., K-2 is due a five percent (5%) commission on all forklift tire sales.  In exchange for the forklift models transferred to Amerityre under that agreement, the first $96,000 in commission payments will be used to extinguish the long term liability recorded on the transaction.  As of September 30, 2021, $2,000 and $61,326 (June 30, 2021, $2,000 and $61,326) were recorded for the current and long-term portion, respectively, of the related liability.

 

 

AMERITYRE CORPORATION

Notes to the Unaudited Condensed Financial Statements

September 30, 2021

 

NOTE 6 STOCK TRANSACTIONS, OPTIONS AND WARRANTS

 

On July 22, 2020, the Board of Directors adopted the 2020 Equity Incentive Plan (the “2020 Plan”) which contains provisions for up to 2,500,000 stock-based instruments to be granted to employees, consultants and directors.

 

On October 26, 2021, the Board of Directors adopted the 2022 Equity Incentive Plan (the “2022 Plan”) which contains provisions for up to 10,000,000 stock-based instruments to be granted to employees, consultants and directors.

 

No stock or options were granted during the fiscal quarter ended September 30, 2021 or thus far in fiscal year 2022.

 

A summary of the status of our outstanding stock options as of September 30, 2021 and June 30, 2021, and changes during these periods is presented below:

 

   

September 30, 2021

   

June 30, 2021

 
           

Weighted Average

   

Intrinsic

           

Weighted Average

   

Intrinsic

 
   

Shares

   

Exercise Price

   

Value

   

Shares

   

Exercise Price

   

Value

 

Outstanding beginning of period

   

1,030,000

   

$

0.12

             

2,870,000

   

$

0.12

         

Granted

   

-

   

$

0.00

             

-

   

$

0.00

         

Expired/Cancelled

   

-

   

$

0.00

             

(1,840,000

)

 

$

0.12

         

Exercised

   

-

   

$

0.00

             

-

   

$

0.00

         

Outstanding end of period

   

1,030,000

   

$

0.12

   

$

-

     

1,030,000

   

$

0.12

   

$

-

 

Exercisable

   

1,030,000

   

$

0.12

   

$

-

     

1,030,000

   

$

0.12

   

$

-

 

 

       

Outstanding

   

Exercisable

 

Range of

Exercise Prices

   

Number Outstanding

at

September 30, 2021

   

Weighted

Average

Remaining

Contractual Life

   

Weighted

Average

Exercise Price

   

Number

Exercisable at

September 30, 2021

   

Weighted

Average Remaining

Contractual Life

 

$

0.08

     

150,000

     

0.17

   

$

0.08

     

150,000

     

0.17

 

$

0.10

     

480,000

     

0.25

   

$

0.10

     

480,000

     

0.25

 

$

0.17

     

400,000

     

0.17

   

$

0.17

     

400,000

     

0.17

 
         

1,030,000

                     

1,030,000

         

 

NOTE 7 – SUBSEQUENT EVENTS

 

On October 26, 2021, the Board of Directors adopted the 2022 Equity Incentive Plan (the “2022 Plan”) which contains provisions for up to 10,000,000 stock-based instruments to be granted to employees, consultants and directors.

 

 

ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

This discussion and analysis contains statements of a forward-looking nature relating to future events or our future financial performance or financial condition.  Such statements are only predictions and the actual events or results may differ materially from the results discussed in or implied by the forward-looking statements.  Factors that could cause or contribute to such differences include, but are not limited to, those discussed in Part I. Item 1A. Risk Factors as well as those discussed elsewhere in this report.  The historical results set forth in this discussion and analyses are not necessarily indicative of trends with respect to any actual or projected future financial performance.  This discussion and analysis should be read in conjunction with the financial statements and the related notes thereto included elsewhere in this report.

 

Overview

 

Amerityre engages in the research and development, manufacturing, and sale of solid polyurethane foam and polyurethane elastomer tires.  We have developed unique polyurethane formulations that allow us to make products with superior performance characteristics, compared to conventional rubber tires, in the areas of abrasion resistance, energy efficiency and load-bearing capabilities.  Our manufacturing processes are more energy efficient than the traditional rubber tire manufacturing processes, in part because our polyurethane compounds do not require the multiple processing steps, extreme heat, and high pressure necessary to cure rubber. We believe tires produced with our proprietary polyurethane formulations last longer, are less susceptible to failure and are friendlier to the environment when compared to competitor offerings.

 

We focus our business on applications and markets where our advantages in product technology, tire performance, and customer service give us an opportunity to obtain premium pricing. Our product development and marketing efforts are focused on building customer relationships and expanding sales with original equipment manufacturers and tire distributors.  Our competitive advantage is creating unique product solutions for customers who have challenging tire performance requirements that cannot be met by competitor offerings.

 

Closed cell Polyurethane Foam Tires – The sale of polyurethane foam tires to original equipment manufacturers, distributors, and dealers accounts for the majority of our sales revenue. We produce a broad range of tire sizes for the light duty tire market, including bicycle tires, hand truck tires, mobility tires, lawn/garden tires, golf car tires, and light industrial vehicle tires.

 

Despite the ongoing negative effects of COVID-19 on the overall US economy, we experienced higher than expected demand for our polyurethane foam tires in the recent quarter. Sales for the fiscal first quarter 2022 were 32.3% higher than the sales level in fiscal first quarter 2021. We continue to see strong sales trends that we saw during fiscal year 2021 as our current customer base is experiencing strong sales and our domestically produced tires are attractive to those new customers looking for a domestic source for their tires

 

Our industrial tire product line, which includes our golf car tires, our 480 x 12 tires, and our 570 x 12 tires, continues to see outstanding demand in the marketplace. We expect this trend to continue in the coming quarters.

 

Polyurethane Elastomer Tires Our elastomer formulations are used to manufacture tires requiring higher levels of abrasion resistance and greater load bearing capability. Forklift tires constitute a large part of this market, with other industrial and agricultural applications representing other opportunities. Overall sales volumes of our forklift tires remain small, less than 0.1% of our total sales revenue. Price sensitive consumers continue to favor imported solid rubber press-on forklift tires rather than our products, and we have not devoted significant resources towards promoting this product line. We have been working with original equipment manufacturers (“OEMs”) to utilize our elastomer formulations for large industrial equipment tires and agricultural applications, which may lead to new revenue sources in the future.

 

Light Density Elastomer Tires – Demand for our light density elastomer formulation (ElastothaneTM 500) in applications requiring greater abrasion resistance and load bearing capability than our polyurethane foam tires. Lawn and garden tire applications continue to drive increased sales of this formulation, although we have seen some custom tire applications for this formulation as well. We expect Agricultural tires sales to continue to increase in the coming quarters as farmers are seeing higher levels of disposable income than they have in years. However, economic challenges such as supply shortages could limit anticipated benefits or our ability to capitalize on them. We continue to approach OEMs and large distributors about promoting and utilizing our tires for certain applications, and several are evaluating sample tires.

 

We believe investment in new and improved products is important to the continued growth and success of our overall business, and we will selectively invest in promising opportunities that can be supported within our current financial model. We have several product evaluations programs ongoing which have the potential to develop into significant future business. We expect our current R&D investments to continue to prove to be a prudent investment of our capital resources.

 

 

A major component of our strategic operating plan is to establish a partnership or other type of business combination with a larger OEM or tire manufacturer who would have a larger distribution channel as well as financial resources to fully leverage our current tire portfolio as well as new products that can be developed using our formulations. The wide availability of capital in the markets has increased the amount of equity investment and merger/acquisition activity in the market. We are open to discussions and will continue to pursue opportunities that we believe will maximize the potential of our intellectual property and the overall value of the business.

 

We continue to face supply chain issues and increases in raw material and operating costs which we expect will continue to pressure our Gross Profit Margins. We implemented another price increase in August 2021 on our tire assemblies to mitigate the effects of these increases in our costs. However, as evidenced by our lower Gross Margins for the quarter, the price increases were not successful at offsetting all cost increases during the quarter. We will continue to closely manage the cost drivers of our business and take appropriate corrective actions, including further price increases where warranted.

 

Our sales growth over the past year has been very strong. However, it is unclear if the environment of rising costs and the corresponding higher sales prices will affect demand for our products moving forward. Raw material availability is also expected to continue to be an issue in the upcoming quarters as the existing supply chain issues are being resolved. While we continue to have a very strong backlog of business, we may be restricted as to how much product we can produce if raw material is not available on a timely basis. We are in constant contact with our suppliers to ensure that negative supply impacts are minimized, although in some cases this may result in Amerityre incurring higher material costs. 

 

As described above, our product line covers diverse market segments which are unrelated in terms of customer base, product distribution, market demands and competition. Our sales team is comprised of independent manufacturer representatives with inside sales support. The Company’s continued emphasis on proper product pricing continues to drive more profitable sales. Our website educates the marketplace about our products as well as offers an outlet for online sales.

 

Factors Affecting Results of Operations

 

Our operating expenses consisted primarily of the following:

 

 

Cost of sales, which consists primarily of raw materials, components and production of our products, including applied labor costs and benefits expenses, maintenance, facilities and other operating costs associated with the production of our products;

 

 

Selling, general and administrative expenses, which consist primarily of salaries, commissions and related benefits paid to our employees and related selling and administrative costs including professional fees;

 

 

Research and development expenses, which consist primarily of  direct labor conducting research and development, equipment and materials used in new product development and product improvement using our technologies;

 

 

Consulting expenses, which consist primarily of amounts paid to third-parties for outside services;

 

 

Depreciation and amortization expenses which result from the depreciation of our property and equipment, including amortization of our intangible assets; and

 

 

Stock based compensation expense related to equity awards issued to directors, employees and consultants for services performed for the Company.

 

Critical Accounting Policies

 

Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with United States generally accepted accounting principles.  The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses.  On an ongoing basis, we evaluate our estimates, including those related to uncollectible receivables, inventory valuation, deferred compensation and contingencies.  We base our estimates on historical performance and on various other assumptions that we believe to be reasonable under the circumstances.  These estimates allow us to make judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.

 

At present we do not have any critical accounting policies that require critical management judgments and estimates about matters that may be uncertain.  

 

 

Results of Operations

 

Our management reviews and analyzes several key performance indicators in order to manage our business and assess the quality and potential variability of our sales and cash flows.  These key performance indicators include:

 

 

Revenues, net of returns and trade discounts, which consists of product sales and services and is an indicator of our overall business growth and the success of our sales and marketing efforts;

 

 

Gross profit, which is an indicator of both competitive pricing pressures and the cost of goods sold of our products and the mix of product and license fees, if any;

 

 

Growth in our customer base, which is an indicator of the success of our sales efforts; and

 

 

Distribution of sales across our products offered.

 

The Company, in light of the impact COVID-19 has had on our business, implemented a price increase on most of its products starting on April 1, 2021. We have seen over the past 10 months significant increases in raw material pricing, caused in part due to supply chain disruptions arising from the COVID-19 pandemic. The January 2021 winter storms in Texas took all polyol manufacturing offline for several weeks as these facilities needed to be repaired and brought back online. Combined with COVID-19-related reductions in propylene manufacturing capacity, the Company was fortunate to receive enough material to maintain operations, albeit at significantly higher prices and an amount that limited our ability to fulfill orders on a timely basis. Shortages of other raw materials in the chemical markets may continue or increase in the coming months, and it is therefore not clear that raw material pricing will return to the lower levels of 2020, or even stabilize at current elevated levels. Management continues to monitor the situation and is prepared to make further product pricing adjustments if necessary. The following paragraphs address these factors and the effects on our business during the fiscal quarter ended September 30, 2021.

 

The following summary table presents a comparison of our results of operations for the fiscal quarters ended September 30, 2021 and 2020 with respect to certain key financial measures.  The comparisons illustrated in the table are discussed in greater detail below.

 

   

Three Month Period Ended September 30,

   

Percent Change

 
   

(in 000’s)

         
   

2021

   

2020

   

2021 vs. 2020

 

Net revenues

  $ 1,396     $ 1,051       32.8

%

Cost of revenues

    (1,011

)

    (708

)

    42.8

%

Gross profit

    385       343       11.9

%

Research  and development expenses

    (22

)

    (20

)

    10.0

%

Sales and marketing expense

    (68

)

    (60

)

    13.3

%

General and administrative expense

    (233

)

    (210

)

    10.4

%

Loss on asset disposal

    -       (3 )     (100.0

)%

Other income

    3       4       (25.0

)%

Net income (loss) attributable to common shareholders

  $ 65     $ 54       20.4

%

 

Quarter Ended September 30, 2021 Compared to September 30, 2020

 

Net Revenues.  Net revenues of $1,395,614 for the quarter ended September 30, 2021, represents an 32.8% increase over net revenues of $1,051,286 for the same period in 2020. These results exceeded our expectations as we continued to navigate the challenges presented by the COVID-19 pandemic, including limited raw material availability, higher supply costs and other supply chain issues. We expect our polyurethane foam products to continue to constitute the majority of our sales going forward.

 

 

Cost of Revenues.  Cost of revenues for the quarter ended September 30, 2021 was $1,010,842 or 72.4% of sales compared to $707,566 or 67.3% of sales for the same period in 2020. We experienced higher raw material costs, particularly chemical feedstocks, during the recent quarter which pressured gross profit margins. Our chemical suppliers have informed us that there will likely be continued price increases in the coming months due to a slow recovery in manufacturing capacity for our raw materials as well as increased market demand. The supply chain issues in procuring material from China has caused higher costs and long delays for our steel rims. We expect these headwinds to continue to pressure our Gross Margins throughout fiscal year 2022. We have mitigated some of these issues by increasing the sales prices of our tires. However, continuing increases in raw material costs may result in reduced product sales if we are forced to turn away sales because they are at price levels that are unprofitable.

 

Gross Profit.  Gross profit for the quarter ended September 30, 2021 was $384,772 compared to $343,720 for the same period in 2020, an increase of $41,052 or 11.9% ,over the same period in 2020.   The September 30, 2021 gross margin reflects a 27.6% gross margin on product sales compared to a gross margin on product sales of 32.7% in 2020. The lower gross profit is the result of higher raw material costs and higher shipping costs on materials purchased from overseas.

 

Research & Development Expenses (R&D).  Research and development expenses for the quarter ended September 30, 2021 were $21,567 compared to $20,471 for the same period in 2020. We continue to invest in product formulation and new product development where appropriate to support our business plan.

 

Sales & Marketing Expenses. Sales and marketing expenses for the quarter ended September 30, 2021 were $68,373 as compared to $59,800 for the same period in 2020. The difference between periods reflects higher commission expenses paid during the recent period due to higher sales volumes.

 

General & Administrative Expenses.  General and administrative expenses for the quarter ended September 30, 2021 were $232,848 compared to $210,486 for the same period in 2020, driven by higher compensation costs. We continue to control costs and find more efficient ways to conduct our business activities.

 

Other Income, net.  Other income for the quarter ended September 30, 2021 was $3,116 compared to other income of $820 for the same period in 2020.

 

Net Income.  Net income for the quarter ended September 30, 2021 of $65,100 compared to $53,783 for the same period in 2020. This represents 20.4% increase in net income compared to the first quarter of fiscal year 2021of $11,317.

 

Liquidity and Capital Resources

 

Cash Flows

 

The following table sets forth our cash flows for the quarters ended September 30, 2021 and 2020.

 

   

Periods ended Sept. 30,

 
   

(in 000’s)

 
   

2021

   

2020

 

Net cash provided (used) by operating activities

  $ 94     $ (48

)

Net cash used by investing activities

    (134

)

    -  

Net cash used by financing activities

    -       -  

Net increase (decrease) in cash during the period

  $ (40

)

  $ (48

)

 

The Company has evaluated its current cash position relative to its cash requirements in the future and has determined its cash levels are sufficient to cover its cash needs. The Company enjoys a strong level of cash on hand as well as an unused credit line facility. These cash resources have been critical during the past year as working capital needs have increased due to the extended time required to receive imported materials (which are paid for when they are ready to ship from the manufacturer, not after they are received for use by the Company) as well as Management’s decision to increase chemical stock levels when extra material became available for purchase. The Company completed its upgrade of its Production pouring systems in September 2021, which was completely paid from cash reserves.

 

 

Our principal sources of liquidity consist of cash on hand and payments received from our customers. In February 2020, the Company secured a $50,000 line of credit with a local community bank. As of September 30, 2021, this credit line had not been used.

 

Historically, the current management team has been reluctant to pursue financing at terms that subject the Company to the high costs of debt, or raise money through the sale of equity at prices we believe do not reflect the true value of the Company. 

 

Cash Position, Outstanding Indebtedness and Future Capital Requirements

 

At November 10, 2021, our total cash balance was $400,035, none of which is restricted; accounts receivables was $474,123; and inventory, net of reserves for slow moving or obsolete inventory, and other current assets was $779,907. Our total indebtedness, specifically which management reviews for cash management, was $774,243 and includes $324,217 in accounts payable and accrued expenses, $2,000 in current portion of long-term debt, $61,326 in long-term debt and $386,700 in total operating lease liability.

 

We continue to take actions to improve our liquidity and access to capital resources. Management continues to maintain that an equity financing in the current market environment would be too dilutive and not in the best interests of our shareholders. We have been successful in securing a line of credit with our bank.

 

In assessing our liquidity, management reviews and analyzes our current cash, accounts receivable, accounts payable, capital expenditure commitments, cash requirements and other obligations.  In connection with the preparation of our financial statements for the fiscal year ended June 30, 2021, we have analyzed our cash needs for the next twelve months. We have concluded that our available cash and accounts receivables are sufficient to meet our current minimum working capital, capital expenditure and other cash requirements for this period.  Although we have seen a significant increase in business activity in recent quarters, there can be no assurance that a resurgence of the COVID-19 virus will not cause a disruption in our markets that causes a significant decrease in demand from our customers. While many government restrictions have been relaxed and the economy has continued to open in more jurisdictions, the emergence of new variants of COVID-19 may lead to possible resurgences of the virus. This could result in new restrictions on our customers located or servicing these affected jurisdictions. Among the adverse consequences caused by the pandemic have been continued supply chain disruptions, resulting in material shortages and delays, as well as increased material costs. The long-term financial impact on our business cannot be reasonably estimated at this time. As a result, the effects of COVID-19 may not be fully reflected in our financial results until future periods. Refer to “Item 1A — Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended June 30, 2021 for a description of the material risks that the Company currently faces including in connection with COVID-19. If there is a new shutdown of the economy, reduction in demand for our products or other adverse effect on our business, we may lack sufficient working capital to meet our needs for the next 12 months.

 

The Company has, on occasion, instituted initiatives to incentivize sales of slower-moving inventory through promotional pricing. These programs will continue to be selectively utilized in the upcoming quarters to monetize inventory, promote individual product lines, and improve our cash flow.

 

As of November 12, 2021, the Company has approximately 23,427,000 shares authorized and available for issuance. Although we are reluctant to raise money through stock sales at what we believe are dilutive share prices, these authorized but unissued and unreserved shares of our common stock can be utilized, if necessary, to raise new funds.

 

Off-Balance Sheet Arrangements

 

We do not currently have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. In addition, we do not engage in trading activities involving non-exchange traded contracts.

 

 

Cautionary Note Regarding Forward Looking Statements

 

This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding economic conditions in general and in the agricultural market, in particular, positive sales trends and resulting profits, our intention to seek out and engage in a partnership or other arrangement with one or more OEMs, our sales prospects in light of new products such as the potential development of tires for large industrial and agricultural equipment, price increases in response to increases in raw material costs and the availability of capital and liquidity. All statements other than statements of historical facts contained in this report, including statements regarding our future financial position, liquidity, business strategy and plans and objectives of management for future operations, are forward-looking statements. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs.

 

These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those described in our Annual Report on Form 10-K for the fiscal year ended June 30, 2021. In addition, there is a risk that the economic repercussions from COVID-19 and supply chain disruptions may be more severe or prolonged than we currently expect, particularly with the new strains emerging and the uncertainty if existing vaccinations will be effective against the new strains, and vaccine hesitancy. Additionally, there is a risk that our price increases or other challenges we face and actions we take in response may result in lower revenues, or that any strategic partnerships or business arrangements do not yield the positive results intended or result in unanticipated adverse consequences, including due to potential friction between the parties. New risk factors emerge from time-to-time and it is not possible for us to predict all such risk factors, nor can we assess the impact of all such risk factors on our business or the extent to which any risk factor, or combination of risk factors, may cause actual results to differ materially from those contained in any forward-looking statements. Except as otherwise required by applicable laws, we undertake no obligation to publicly update or revise any forward-looking statements described in this report, whether as a result of new information, future events, changed circumstances or any other reason after the date this report is filed.

 

 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable.

 

ITEM 4. CONTROLS AND PROCEDURES

 

The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

 

As required by SEC Rule 13a-15(b), an evaluation was performed under the supervision and with the participation of our management, including our Chief Executive and Financial Officers, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) as of the end of the period covered by this report. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that the design and operation of these disclosure controls and procedures were effective at the reasonable assurance level as of the end of the period covered by this quarterly report to ensure the information required to be disclosed by us in reports is timely recorded, processed, summarized and reported in accordance with the SEC’s rules and forms and communicated to our management as appropriate to allow timely decisions regarding required disclosure.

 

 

 

 

 

PART II - OTHER INFORMATION

 

ITEM 1.  LEGAL PROCEEDINGS

 

None.

 

ITEM 1A. RISK FACTORS

 

For information regarding risk factors, see “Part I. Item 1A. Risk Factors,” in our 2021 Annual Report.

 

ITEM 2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4.  MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5.  OTHER INFORMATION

 

Our Annual Stockholders’ Meeting is scheduled for 10:00 am, Pacific Time on Wednesday, December 1, 2021 virtually. For more information about the Annual Stockholders’ Meeting, see the Company’s Definitive Proxy Statement on Schedule 14A which was filed with the Securities and Exchange Commission and mailed to our stockholders of record on October 22, 2021.

 

ITEM 6.  EXHIBITS

 

       

Incorporated by Reference

 

Filed or Furnished

Exhibit #

 

Exhibit Description

 

Form

 

Date

 

Number

 

Herewith

3.1

 

Articles of Incorporation of the Company

 

8-A12G

 

10/28/02

 

3.01

   

3.2

 

Certificate of Amendment to the Articles of Incorporation of the Company

 

8-A12G

 

10/28/02

 

3.01

   

3.3

 

Certificate of Amendment to the Articles of Incorporation

 

10-Q

 

2/14/13

 

3(i)

   

3.4

 

Certificate of Amendment to the Articles of Incorporation

 

8-K

 

6/1/20

 

3.1

   

3.5

 

Bylaws of the Company

 

8-K

 

9/25/13

 

3.02

   

31.1

 

Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

             

Filed

31.2

 

Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

             

Filed

32.1

 

Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

             

Filed

32.2

 

Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

             

Filed

101 INS

 

XBRL Instance Document

               

101 SCH

 

XBRL Taxonomy Extension Schema Document

             

Filed

101 CAL

 

XBRL Taxonomy Extension Calculation Linkbase Document

             

Filed

101 DEF

 

XBRL Taxonomy Extension Definition Linkbase Document

             

Filed

101 LAB

 

XBRL Taxonomy Extension Label Linkbase Document

             

Filed

101 PRE

 

XBRL Taxonomy Extension Presentation Linkbase Document

             

Filed

104

 

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

               

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated:  November 15, 2021

 

AMERITYRE CORPORATION

     

By:

     

/s/ Michael F. Sullivan

 

/s/ Lynda R. Keeton-Cardno

 

Michael F. Sullivan

Chief Executive Officer

(Principal Executive Officer)

 

Lynda R. Keeton-Cardno

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

 

 

 

 

18
NV false --06-30 Q1 2022 0000945828 0000945828 2021-07-01 2021-09-30 0000945828 2021-11-15 0000945828 2021-09-30 0000945828 2021-06-30 0000945828 2020-07-01 2020-09-30 0000945828 us-gaap:CommonStockMember 2020-06-30 0000945828 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0000945828 us-gaap:RetainedEarningsMember 2020-06-30 0000945828 2020-06-30 0000945828 amty:StockPayableMember 2020-07-01 2020-09-30 0000945828 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0000945828 us-gaap:CommonStockMember 2020-09-30 0000945828 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0000945828 amty:StockPayableMember 2020-09-30 0000945828 us-gaap:RetainedEarningsMember 2020-09-30 0000945828 2020-09-30 0000945828 amty:StockPayableMember 2020-10-01 2020-12-31 0000945828 2020-10-01 2020-12-31 0000945828 us-gaap:CommonStockMember 2020-10-01 2020-12-31 0000945828 us-gaap:AdditionalPaidInCapitalMember 2020-10-01 2020-12-31 0000945828 us-gaap:RetainedEarningsMember 2020-10-01 2020-12-31 0000945828 us-gaap:CommonStockMember 2020-12-31 0000945828 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000945828 us-gaap:RetainedEarningsMember 2020-12-31 0000945828 2020-12-31 0000945828 amty:StockPayableMember 2021-01-01 2021-03-31 0000945828 2021-01-01 2021-03-31 0000945828 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0000945828 us-gaap:CommonStockMember 2021-03-31 0000945828 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0000945828 amty:StockPayableMember 2021-03-31 0000945828 us-gaap:RetainedEarningsMember 2021-03-31 0000945828 2021-03-31 0000945828 amty:StockPayableMember 2021-04-01 2021-06-30 0000945828 2021-04-01 2021-06-30 0000945828 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0000945828 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0000945828 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0000945828 us-gaap:CommonStockMember 2021-06-30 0000945828 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0000945828 us-gaap:RetainedEarningsMember 2021-06-30 0000945828 amty:StockPayableMember 2021-07-01 2021-09-30 0000945828 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0000945828 us-gaap:CommonStockMember 2021-09-30 0000945828 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0000945828 amty:StockPayableMember 2021-09-30 0000945828 us-gaap:RetainedEarningsMember 2021-09-30 0000945828 amty:ShippingAndHandlingRevenueMember 2021-07-01 2021-09-30 0000945828 amty:ShippingAndHandlingRevenueMember 2020-07-01 2020-09-30 0000945828 2019-03-31 0000945828 us-gaap:BuildingMember 2019-03-31 0000945828 srt:MinimumMember 2021-07-01 2021-09-30 0000945828 srt:MaximumMember 2021-07-01 2021-09-30 0000945828 us-gaap:NotesPayableOtherPayablesMember 2021-07-01 2021-09-30 0000945828 us-gaap:NotesPayableOtherPayablesMember 2021-09-30 0000945828 us-gaap:NotesPayableOtherPayablesMember 2021-06-30 0000945828 amty:Equity2020IncentivePlanthe2020PlanMember 2020-07-22 0000945828 amty:EquityIncentivePlanthe2022PlanMember 2021-10-26 0000945828 2020-07-01 2021-06-30 0000945828 amty:OptionsAt0.08Member 2021-09-30 0000945828 amty:OptionsAt0.08Member 2021-07-01 2021-09-30 0000945828 amty:OptionsAt0.10Member 2021-09-30 0000945828 amty:OptionsAt0.10Member 2021-07-01 2021-09-30 0000945828 amty:OptionsAt017Member 2021-09-30 0000945828 amty:OptionsAt017Member 2021-07-01 2021-09-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares utr:sqft utr:acre xbrli:pure
Amerityre (PK) (USOTC:AMTY)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Amerityre (PK) Charts.
Amerityre (PK) (USOTC:AMTY)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Amerityre (PK) Charts.